News & Analysis as of September 26, 2024

Medicaid › Antitrust Division

+ Follow

Medicaid is a partnership program between states and the federal government to provide healthcare coverage for lower income individuals, people with disabilities, older people, and certain families with... more +

The State AG Report – 6.29.2023

Cozen O'Connor on 7/3/2023

Here are curated AG and federal regulatory news stories highlighting key areas in which state and federal regulators’ decisions are having an impact across the US: •SmileDirectClub’s NDAs Required Dissatisfied Customers to...more

The Department of Justice’s Withdrawal of Three Antitrust Statements and the Impact on Health Care Organizations

Ankura on 5/3/2023

On February 3, 2023, the Department of Justice Antitrust Division (DOJ) announced the withdrawal of three policy statements that have long guided the information exchanges as well as the related enforcement in the healthcare...more

Growing Scrutiny of Private Equity in Health Care

Foley & Lardner LLP on 3/30/2023

The presence of private equity (PE) investment has exploded in recent years in all areas of the health care sector. PE in health care is a good thing when done right: It can pave the way for much needed innovation,...more

Antitrust Division Indicts Four Individuals for Wage Fixing in Labor Markets (Part III of III)

The Volkov Law Group on 2/3/2022

Criminal antitrust is burning a path in prosecuting illegal wage-fixing agreements in labor markets. The Justice Department warned companies over five years ago and now DOJ is executing on its warning. Over the last two...more

President Biden Issues Executive Order Including Provisions To Promote Generic Drug and Biosimilar Competition in the American...

Goodwin on 7/20/2021

On July 9, President Biden issued an Executive Order regarding competition in various sectors of the United States economy, including the healthcare market. Among the 72 initiatives set forth in the Order are instructions...more

Health Plan Transactions: Trends and Issues

Manatt, Phelps & Phillips, LLP on 6/27/2019

Editor’s Note: The number of healthcare transactions reached a record-smashing 1,738 in 2018. According to a new Capital One poll, mergers and acquisitions are the preferred growth vehicle for 44% of healthcare executives in...more

The Government’s Generic Price-Fixing Investigation Targets Allergan’s Actavis Unit

Patterson Belknap Webb & Tyler LLP on 8/19/2015

This is our fourth post on the DOJ’s expanding investigation into possible price fixing by generic drug manufacturers. (Click here, here, and here to read our prior posts.) Since our last update, the DOJ has subpoenaed...more

7 Results

View per page

Page: of 1